We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Bio-Rad Exhibits Range of Solutions for Maximizing Lab Efficiency at AACC

By LabMedica International staff writers
Posted on 26 Jul 2022
Print article
Image: Visitors to the company’s booth at AACC 2022 saw a range of solutions that support labs by maximizing efficiency (Photo courtesy of Bio-Rad)
Image: Visitors to the company’s booth at AACC 2022 saw a range of solutions that support labs by maximizing efficiency (Photo courtesy of Bio-Rad)

At the 2022 AACC Clinical Lab Expo, Bio-Rad Laboratories (Hercules, CA, USA) is presenting its range of solutions that support labs by maximizing efficiency through streamlining workflows, consolidating platforms, improving turnaround time and gaining confidence in results.

Bio-Rad is exhibiting its quality control solutions that help streamline workflows, reduce errors, maintain compliance, and facilitate accreditation—improving efficiency and saving money. These solutions included its InteliQ Load-and-Go Controls that can transform QC workflow with load-and-go-efficiency. InteliQ quality controls, a smarter way to manage QC, help automate workflow - reducing turnaround time, limiting manual errors, and increasing overall efficiency. Bio-Rad will also present its Unity QC Data Management Solutions that help achieve greater efficiency while reducing costs. In addition to identifying trends and making corrections before results are compromised, connectivity to the world’s largest community of QC users brings the confidence and reliability to stand behind the results. Also on display will be the company’s comprehensive line of molecular quality controls, standards, and data management solutions that streamline workflow and set a new standard in molecular lab performance.

Visitors at Bio-Rad’s AACC 2022 booth can experience its D-100 hemoglobin testing system, a fully automated, best-in-class HbA1c analyzer featuring a highly evolved combination of hardware, software and chemistry for high-volume labs, and the BioPlex 2200 System, which consolidates autoimmune, infectious disease, and vitamin D testing all on one fully automated, track line compatible, random-access platform. Also on display at the event will be IH-500, the latest addition to the Bio-Rad IH-Complete family of immunohematology testing systems that delivers an easy-to-use, fully automated system with random access and minimal user intervention. In addition, Bio-Rad is showcasing the IH-Reader 24, a combination centrifuge and reader for convenient and intelligent processing of manually pipetted IH-Gel Cards; the IH-1000 fully automated, walk-away system for ID-Cards with high-throughput, continuous sample and reagent loading; and the IH-Centrifuge L and IH-Incubator L, small but powerful members of the IH-Complete family that allow labs of all sizes to standardize gel and tube applications.
 

Related Links:
Bio-Rad Laboratories 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.